ANKRD40CL
gene geneOn this page
Also known as FLJ20694
Summary
ANKRD40CL (ANKRD40 C-terminal like, HGNC:26080) is a protein-coding gene on chromosome 17q21.33, encoding Putative ANKRD40 C-terminal-like protein (Q53H64).
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001358683
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26080 |
| Approved symbol | ANKRD40CL |
| Name | ANKRD40 C-terminal like |
| Location | 17q21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20694 |
| Ensembl gene | ENSG00000167117 |
| Ensembl biotype | protein_coding |
| Entrez | 55018 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 13 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000300458, ENST00000419688, ENST00000450727, ENST00000502517, ENST00000576150, ENST00000643007, ENST00000895515, ENST00000943667, ENST00000943668, ENST00000943669, ENST00000943670, ENST00000943671, ENST00000943672, ENST00000943673, ENST00000943674, ENST00000943675
RefSeq mRNA: 2 — MANE Select: NM_001358683
NM_001358683, NM_001411123
CCDS: CCDS86616, CCDS92359
Canonical transcript exons
ENST00000450727 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001669087 | 50761030 | 50761506 |
| ENSE00001704985 | 50767463 | 50767518 |
| ENSE00001709401 | 50763397 | 50763557 |
| ENSE00003831191 | 50766874 | 50767011 |
Expression profiles
Bgee: expression breadth broad, 89 present calls, max score 95.30.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2731 / max 166.7423, expressed in 19 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166995 | 0.1935 | 18 |
| 166996 | 0.0796 | 19 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 95.30 | gold quality |
| jejunal mucosa | UBERON:0000399 | 94.34 | gold quality |
| duodenum | UBERON:0002114 | 91.57 | gold quality |
| rectum | UBERON:0001052 | 89.96 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.43 | gold quality |
| colonic mucosa | UBERON:0000317 | 84.55 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 83.89 | gold quality |
| small intestine | UBERON:0002108 | 83.49 | gold quality |
| transverse colon | UBERON:0001157 | 81.65 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 81.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.84 | gold quality |
| secondary oocyte | CL:0000655 | 75.91 | gold quality |
| jejunum | UBERON:0002115 | 74.15 | gold quality |
| intestine | UBERON:0000160 | 73.90 | gold quality |
| buccal mucosa cell | CL:0002336 | 72.34 | silver quality |
| oocyte | CL:0000023 | 72.14 | gold quality |
| ileal mucosa | UBERON:0000331 | 71.34 | gold quality |
| ileum | UBERON:0002116 | 71.31 | silver quality |
| large intestine | UBERON:0000059 | 70.71 | gold quality |
| colonic epithelium | UBERON:0000397 | 70.15 | gold quality |
| colon | UBERON:0001155 | 70.04 | gold quality |
| vermiform appendix | UBERON:0001154 | 61.76 | gold quality |
| gall bladder | UBERON:0002110 | 61.33 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 59.25 | gold quality |
| caecum | UBERON:0001153 | 58.39 | gold quality |
| mammary duct | UBERON:0001765 | 55.11 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 54.92 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 49.31 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.82 |
| E-GEOD-124858 | no | 6.85 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Knock-down of Long non-coding RNA Linc00483 inhibited the development of cervical cancer by regulating miR-508-3p/RGS17 axis. (PMID:31454494)
- LINC00483 is regulated by IGF2BP1 and participates in the progression of breast cancer. (PMID:33629308)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ankrd40 | ENSDARG00000076490 |
| mus_musculus | Ankrd40cl | ENSMUSG00000094091 |
| rattus_norvegicus | Ankrd40cl | ENSRNOG00000045669 |
Paralogs (1): ANKRD40 (ENSG00000154945)
Protein
Protein identifiers
Putative ANKRD40 C-terminal-like protein — Q53H64 (reviewed: Q53H64)
All UniProt accessions (3): A0A2R8Y365, A0A2R8YGP7, Q53H64
RefSeq proteins (2): NP_001345612, NP_001398052 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039195 | ANKRD40 | Family |
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53H64-F1 | 78.33 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
AAAGACA_MIR511, E2F2_TARGET_GENES, ELF2_TARGET_GENES, ZNF507_TARGET_GENES, DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS, DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS, DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS, LHX2_TARGET_GENES, GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN, GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP, GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN, chr17q21, GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP, PAX_Q6, GGGYGTGNY_UNKNOWN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
412 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKRD40CL | DOC2B | Q14184 | 370 |
| ANKRD40CL | RTN4RL1 | Q86UN2 | 367 |
| ANKRD40CL | CATSPER1 | Q8NEC5 | 355 |
| ANKRD40CL | MIEN1 | Q9BRT3 | 349 |
| ANKRD40CL | PPP1R12C | Q9BZL4 | 348 |
| ANKRD40CL | DDX17 | Q92841 | 346 |
| ANKRD40CL | DLX4 | Q92988 | 322 |
| ANKRD40CL | TRIM37 | O94972 | 307 |
| ANKRD40CL | AGGF1 | Q8N302 | 304 |
| ANKRD40CL | FMNL2 | Q96PY5 | 297 |
| ANKRD40CL | PREB | Q9HCU5 | 280 |
| ANKRD40CL | SEC13 | P55735 | 280 |
| ANKRD40CL | ARCN1 | P48444 | 279 |
| ANKRD40CL | COPB2 | P35606 | 279 |
| ANKRD40CL | COPA | P53621 | 279 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0G2JXT6, A0A1B0GW35, A6H5X4, B9EK06, F4I7Y2, F6QZ15, J9SQF3, O35309, O82617, O88509, O95789, P0CL83, P0DOY1, P35125, P83946, P86265, Q02395, Q10NJ6, Q13287, Q1L721, Q1LZ50, Q2RBJ4, Q3SZ89, Q3ZCL3, Q4R6N0, Q53H64, Q569R5, Q5E9T7, Q5F476, Q5H9U9, Q5I0J8, Q5R7T9, Q6AXW4, Q7X7E9, Q7Z569, Q8BVM9, Q8L7A4, Q8TBR4, Q99388, Q9BWX1
Diamond homologs: Q53H64, Q5SUE8, Q6AI12, P0C0T2, Q05823, Q09103, Q3V096, Q4R7L8, Q5RCK5, Q5RD76, Q68DC2, Q6GQX6, Q9BQG2, Q8N9B4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
746 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:50763526:G:C | F24L | 0.955 |
| 17:50763526:G:T | F24L | 0.955 |
| 17:50763528:A:G | F24L | 0.955 |
| 17:50763469:A:C | S43R | 0.922 |
| 17:50763469:A:T | S43R | 0.922 |
| 17:50763471:T:G | S43R | 0.922 |
| 17:50763400:T:A | R66S | 0.905 |
| 17:50763400:T:G | R66S | 0.905 |
| 17:50763424:T:A | R58S | 0.892 |
| 17:50763424:T:G | R58S | 0.892 |
| 17:50763421:C:A | K59N | 0.851 |
| 17:50763421:C:G | K59N | 0.851 |
| 17:50763557:A:T | V14D | 0.828 |
| 17:50761489:T:A | R73S | 0.821 |
| 17:50761489:T:G | R73S | 0.821 |
| 17:50763417:G:A | P61S | 0.802 |
| 17:50763401:C:G | R66T | 0.798 |
| 17:50763404:A:T | L65H | 0.794 |
| 17:50763428:A:G | I57T | 0.788 |
| 17:50763553:T:A | R15S | 0.785 |
| 17:50763553:T:G | R15S | 0.785 |
| 17:50763520:T:A | E26D | 0.784 |
| 17:50763520:T:G | E26D | 0.784 |
| 17:50763425:C:G | R58T | 0.782 |
| 17:50763416:G:A | P61L | 0.780 |
| 17:50761474:C:A | Q78H | 0.777 |
| 17:50761474:C:G | Q78H | 0.777 |
| 17:50763529:G:C | D23E | 0.770 |
| 17:50763529:G:T | D23E | 0.770 |
| 17:50761500:C:G | D70H | 0.766 |
dbSNP variants (sampled 300 via entrez): RS1000075771 (17:50760661 G>A), RS1000209732 (17:50768714 C>T), RS1000304423 (17:50769010 T>A,C), RS1000317187 (17:50767002 G>A,T), RS1000357534 (17:50761966 G>A,T), RS1000641674 (17:50767704 G>A,C), RS1000722958 (17:50760593 A>G), RS1000792314 (17:50762272 G>A), RS1001193415 (17:50761433 A>T), RS1001374528 (17:50766658 T>C), RS1001625227 (17:50761845 A>G), RS1002009254 (17:50767060 G>A,C), RS1002379045 (17:50765158 A>G), RS1003387093 (17:50763475 G>A), RS1003416617 (17:50763781 T>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| bisphenol F | decreases methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.